<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03207035</url>
  </required_header>
  <id_info>
    <org_study_id>ECM 4 (mm)</org_study_id>
    <nct_id>NCT03207035</nct_id>
  </id_info>
  <brief_title>Effect of Local Anaesthetic Dilution on the Characteristics of Ultrasound Guided Axillary Brachial Plexus Block</brief_title>
  <official_title>Effect of Local Anaesthetic Dilution on the Characteristics of Ultrasound Guided Axillary Brachial Plexus Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cork University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cork University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We propose to compare the effects of local anaesthetic dilution on the characteristics of the&#xD;
      ultrasound guided axillary brachial plexus block.&#xD;
&#xD;
      Administration of 40ml lidocaine 1% with epinephrine will shorten the onset time of&#xD;
      ultrasound guided axillary brachial plexus block when compared to 20 mL lidocaine 2% with&#xD;
      epinephrine for elective upper limb surgical procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare the effects of local anaesthetic 20 mL lidocaine 1% with epinephrine vs 40 mL&#xD;
      lidocaine 1% with epinephrine on the onset of sensory and motor block following ultrasound&#xD;
      guided axillary brachial plexus block.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      It is a prospective, randomized, observer blinded study. With institutional ethical approval&#xD;
      and having obtained written informed consent from each, 20 patients will be studied.&#xD;
&#xD;
      Randomisation and blinding:&#xD;
&#xD;
      Using a computer generated and sealed envelope technique, 20 patients will be randomly&#xD;
      allocated in to one of two groups.&#xD;
&#xD;
      Group 1: patients will receive 20 ml of lidocaine 2% with epinephrine. Group 2: patients will&#xD;
      receive 40 ml of lidocaine 1% with epinephrine.&#xD;
&#xD;
      Sample size and statistical analysis:&#xD;
&#xD;
      In the absence of data from previous study using 20 ml of lidocaine with epinephrine for&#xD;
      ultrasound guided axillary brachial plexus block. Sample size was calculated based on from&#xD;
      our pilot study of 12 patients. We found mean onset of block of 11.25 (SD, 2.3) mins. The&#xD;
      minimum sample size required to have an 80% probability of detecting a 30% decrease in onset&#xD;
      time (level of significance 0.05) will be 7 patients per group using an unpaired student's t&#xD;
      test. Recruited 10 per group&#xD;
&#xD;
      Anaesthetic procedure:&#xD;
&#xD;
      Having established intravenous access, standard anaesthetic monitoring will be applied.&#xD;
      Premedication with midazolam will be administered as clinically indicated (to a maximum of 3&#xD;
      mg). The operative arm will be abducted and externally rotated with elbow flexed at 90&#xD;
      degrees. Under strict aseptic condition, ultrasound guided axillary brachial plexus block&#xD;
      will be performed. Having identified musculocutaneous, median, radial and ulnar nerves, a&#xD;
      50mm 24-gauge stimuplex short bevel insulated needle will be used with in-plane approach to&#xD;
      block each nerve with either 5 (Group 1) or 10 ml (Group 2). All blocks will be performed by&#xD;
      operator experienced in the ultrasound peripheral nerve blocks.&#xD;
&#xD;
      Block assessment:&#xD;
&#xD;
      When the block procedure has been completed, a blinded observer will assess the onset of&#xD;
      sensory and motor block in the innervation of each nerve every 2.5 mins, until surgical&#xD;
      anaesthesia is achieved or 30 mins have elapsed (Table 1). Surgical anaesthesia will be&#xD;
      defined as a motor score ≤2, with absent sensation to cold and pinprick. Each nerve&#xD;
      distribution will be individually assessed. Onset time will be measured from conclusion of&#xD;
      the block (t=0) to attainment of surgical anaesthesia. Block will be deemed failure if&#xD;
      surgical anaesthesia has not been achieved at 30 mins in one or more of the four nerve&#xD;
      distribution. In case of failure, an additional rescue block or conversion to general&#xD;
      anaesthesia will be performed. DATA from these patients will be analysed separately.&#xD;
&#xD;
      Intraoperative period:&#xD;
&#xD;
      All patients will receive 1 g of paracetamol and diclofenac 75 mg iv during surgery. In case&#xD;
      of patients discomfort sedation and rescue analgesia in the form of fentanyl 25 micrograms&#xD;
      aliquots IV will be administered to a maximum of 100 micrograms.&#xD;
&#xD;
      Postoperative period:&#xD;
&#xD;
      Upon arrival to recovery room, sensory and motor function will be assessed every 15 mins by a&#xD;
      blinded observer.15 Assessment will be performed for each nerve separately. Block regression&#xD;
      is defined as a return of sensation to cold and pinprick with motor power score ≥3 in any&#xD;
      nerve region. Time to first request for postoperative analgesia and total opioid consumption&#xD;
      for 24 hrs will be noted. Postoperative analgesia will be prescribed as paracetamol 1 g 6&#xD;
      hourly and diclofenac sodium 75 mg 12 hourly. Oxycodone 5-10 mg orally 4-6 hourly will be&#xD;
      administered as rescue analgesia.&#xD;
&#xD;
      Primary Outcome: onset of block.&#xD;
&#xD;
      Secondary Outcomes: Duration of sensory and motor block and block performance data (Imaging&#xD;
      time, Needling time, Performance time, No of needle pass, Vascular puncture and parasthesia)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2014</start_date>
  <completion_date type="Actual">March 14, 2016</completion_date>
  <primary_completion_date type="Actual">March 14, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Onset of Axillary Block</measure>
    <time_frame>1 day</time_frame>
    <description>Time taken for onset of sensory and motor axillary brachial plexus block</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of Sensory and Motor Block</measure>
    <time_frame>1 day</time_frame>
    <description>Total duration of sensory and motor block of ultrasound guided axillary brachial plexus block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block Performance Data- Imaging Time</measure>
    <time_frame>1 Hour</time_frame>
    <description>Time taken to obtain appropriate ultrasound image to perform the axillary plexus block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Needling Time</measure>
    <time_frame>1Hour</time_frame>
    <description>Time taken to perform the block in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance Time</measure>
    <time_frame>1 Hour</time_frame>
    <description>Sum of imaging and performance time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>No of Needle Pass</measure>
    <time_frame>1 Hour</time_frame>
    <description>Number of needle passes while performing the axillary block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular Puncture</measure>
    <time_frame>1 Hour</time_frame>
    <description>Incidence of vascular puncture during the performance of block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parasthesia</measure>
    <time_frame>1 Hour</time_frame>
    <description>Incidence of parasthesia during the performance of axillary block</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Brachial Plexus Blockade</condition>
  <arm_group>
    <arm_group_label>20 ml of lidocaine 2% with epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>40 ml 0f lidocaine 1% with epinephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Axillary brachial plexus block</intervention_name>
    <description>Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
    <arm_group_label>20 ml of lidocaine 2% with epinephrine</arm_group_label>
    <arm_group_label>40 ml 0f lidocaine 1% with epinephrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA 1-3&#xD;
&#xD;
          -  Patients aged &gt;18 years undergoing elective upper limb (forearm or hand) surgical&#xD;
             procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications to regional anaesthesia&#xD;
&#xD;
          -  Hypersensitivity to amide local anaesthetics.&#xD;
&#xD;
          -  Chronic pain&#xD;
&#xD;
          -  Language barrier&#xD;
&#xD;
          -  Neuromuscular disorders or peripheral neuropathy&#xD;
&#xD;
          -  Body mass index &gt; 35&#xD;
&#xD;
          -  History of hepatic and renal insufficiency&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Cognitive or psychiatric disorder&#xD;
&#xD;
          -  Cardiac conduction abnormality.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anil Ranganath, FCAI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cork University Hospital</affiliation>
  </overall_official>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 7, 2017</study_first_submitted>
  <study_first_submitted_qc>June 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <results_first_submitted>August 7, 2021</results_first_submitted>
  <results_first_submitted_qc>October 14, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 18, 2021</results_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cork University Hospital</investigator_affiliation>
    <investigator_full_name>Dr Anil Ranganath</investigator_full_name>
    <investigator_title>Dr (Fellow in Regional Anaesthesia)</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrollment&#xD;
Assessed for eligibility: n=45 Excluded : n= 25&#xD;
Not meeting inclusion criteria: n = 5&#xD;
Declined to participate: n = 20&#xD;
Randomized: n= 20</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>20 ml of Lidocaine 2% With Epinephrine</title>
          <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
        </group>
        <group group_id="P2">
          <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
          <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>20 ml of Lidocaine 2% With Epinephrine</title>
          <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
        </group>
        <group group_id="B2">
          <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
          <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.8" spread="18.2"/>
                    <measurement group_id="B2" value="48" spread="15.7"/>
                    <measurement group_id="B3" value="47.4" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ireland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Onset of Axillary Block</title>
        <description>Time taken for onset of sensory and motor axillary brachial plexus block</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>20 ml of Lidocaine 2% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
          <group group_id="O2">
            <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
        </group_list>
        <measure>
          <title>Onset of Axillary Block</title>
          <description>Time taken for onset of sensory and motor axillary brachial plexus block</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.75" lower_limit="7.5" upper_limit="10"/>
                    <measurement group_id="O2" value="6.25" lower_limit="5" upper_limit="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Sensory and Motor Block</title>
        <description>Total duration of sensory and motor block of ultrasound guided axillary brachial plexus block</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>20 ml of Lidocaine 2% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
          <group group_id="O2">
            <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Sensory and Motor Block</title>
          <description>Total duration of sensory and motor block of ultrasound guided axillary brachial plexus block</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="165.1" spread="5.9"/>
                    <measurement group_id="O2" value="150.9" spread="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Block Performance Data- Imaging Time</title>
        <description>Time taken to obtain appropriate ultrasound image to perform the axillary plexus block</description>
        <time_frame>1 Hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>20 ml of Lidocaine 2% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
          <group group_id="O2">
            <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
        </group_list>
        <measure>
          <title>Block Performance Data- Imaging Time</title>
          <description>Time taken to obtain appropriate ultrasound image to perform the axillary plexus block</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="0.5"/>
                    <measurement group_id="O2" value="2.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.70</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Needling Time</title>
        <description>Time taken to perform the block in minutes</description>
        <time_frame>1Hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>20 ml of Lidocaine 2% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
          <group group_id="O2">
            <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
        </group_list>
        <measure>
          <title>Needling Time</title>
          <description>Time taken to perform the block in minutes</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" spread="1.2"/>
                    <measurement group_id="O2" value="6.7" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Performance Time</title>
        <description>Sum of imaging and performance time</description>
        <time_frame>1 Hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>20 ml of Lidocaine 2% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
          <group group_id="O2">
            <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
        </group_list>
        <measure>
          <title>Performance Time</title>
          <description>Sum of imaging and performance time</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.9" spread="1.3"/>
                    <measurement group_id="O2" value="9.1" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>No of Needle Pass</title>
        <description>Number of needle passes while performing the axillary block</description>
        <time_frame>1 Hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>20 ml of Lidocaine 2% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
          <group group_id="O2">
            <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
        </group_list>
        <measure>
          <title>No of Needle Pass</title>
          <description>Number of needle passes while performing the axillary block</description>
          <units>Needle passes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.5" spread="2.3"/>
                    <measurement group_id="O2" value="9.1" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vascular Puncture</title>
        <description>Incidence of vascular puncture during the performance of block.</description>
        <time_frame>1 Hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>20 ml of Lidocaine 2% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
          <group group_id="O2">
            <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
        </group_list>
        <measure>
          <title>Vascular Puncture</title>
          <description>Incidence of vascular puncture during the performance of block.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.53</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Parasthesia</title>
        <description>Incidence of parasthesia during the performance of axillary block</description>
        <time_frame>1 Hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>20 ml of Lidocaine 2% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
          <group group_id="O2">
            <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
            <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
          </group>
        </group_list>
        <measure>
          <title>Parasthesia</title>
          <description>Incidence of parasthesia during the performance of axillary block</description>
          <units>Parasthesia events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.48</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day</time_frame>
      <desc>The incidence of adverse effects perioperatively: nausea, dizziness, tinnitus, vomiting, convulsions or arrhythmia.</desc>
      <group_list>
        <group group_id="E1">
          <title>20 ml of Lidocaine 2% With Epinephrine</title>
          <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 2% with epinephrine.&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
        </group>
        <group group_id="E2">
          <title>40 ml 0f Lidocaine 1% With Epinephrine</title>
          <description>Patients will receive axillary brachial plexus block with 20 ml of lidocaine 1% with epinephrine diluted with 20 ml of nacl 0.9% ( total 40 ml)&#xD;
Axillary brachial plexus block: Ultrasound guided axillary brachial plexus block with local anaesthetic lidocaine with epinephrine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Anil Ranganath</name_or_title>
      <organization>Cork University Hospital</organization>
      <email>drmrak.2@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

